The cost of prescription medicines used by millions of people every day is about to plummet. The next 14 months will bring generic versions of seven of the world's 20 best-selling drugs, including the ...

Starting in October, drug companies will start rolling out generic versions of several widely used but expensive drugs. The top two sellers are the cholesterol drug Lipitor and the blood-thinner ...

Bristol-Myers Squibb Co. and Sanofi-Aventis on Thursday won a bid to stop Apotex Inc. from selling its cheaper generic version of the Plavix heart pill, the world’s second-biggest-selling medicine.

AP - The cost of prescription medicines used by millions of people every day is about to plummet. The next 14 months will bring generic versions of seven of the world's 20 best-selling drugs, ...

Here's what's making health news this morning: FDA Approves Generic Version of Plavix (WSJ): The patent on the drug used to ward off heart attacks and strokes in people with cardiovascular disease ...

Bristol-Myers Squibb said generic competition on its biggest drug, Plavix, hamstrung third-quarter earnings, while a federal probe expanded to determine whether an ill-fated deal to protect the Plavix ...

Texas Attorney General Ken Paxton has launched a lawsuit against pharmaceutical giants Sanofi and Bristol-Myers Squibb, ...

Generic competition will decimate sales of the brand-name drugs and slash the cost to patients and companies that provide health benefits. Top drugs getting generic competition by September 2012 are ...

PARIS/LONDON, Oct 5 (Reuters) - French drugmaker Sanofi-Aventis is preparing to sell its own generic version of the blockbuster heart medicine Plavix in France, a company spokesman said on Monday.

This article was originally on a blog post platform and may be missing photos, graphics or links. See About archive blog posts. The Food and Drug Administration said Friday that it will require a new ...

Bristol faces a setback in the plavix litigation. Eli Lilly has trouble with Jardiance. Bellerophon gets FDA approval for COVID-19. Looking for more stock ideas like this one? Get them exclusively at ...